The Responsibilities and Standing Rules, and Care and Support (Miscellaneous Amendments) Regulations 2018
Citation and commencement1.
(1)
These Regulations may be cited as the Responsibilities and Standing Rules, and Care and Support (Miscellaneous Amendments) Regulations 2018.
(2)
Save as provided in paragraphs (3) and (4), these Regulations come into force on 1st April 2018.
(3)
Regulation 2—
(a)
paragraphs (2)(a) and (d) and (3), come into force on 1st October 2018;
(b)
paragraph (4)(a), comes into force on 1st April 2019;
(c)
paragraph (4)(c), (d) and (e), comes into force on 1st April 2020.
(4)
Regulations 3 and 4 come into force on 1st October 2018.
Amendment of the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 20122.
(1)
(2)
In regulation 20 (interpretation), in paragraph (1), in the definition of—
(a)
(b)
“flat rate payment” for “£155.05” substitute “£158.16”;
(c)
“high band payment” for “£213.32” substitute “£217.59”;
(d)
(e)
“nursing care by a registered nurse” (which is included in the definition of “nursing care”), for “section 49(2) of the Health and Social Care Act 2001” substitute “section 22(8) of the Care Act 2014”;
(f)
“regulated activity” for “2010” substitute “2014”.
(3)
In regulation 21 (duty of relevant bodies: assessment and provision of NHS continuing healthcare)—
(a)
(b)
(c)
in paragraph (13), in the definition of “multi-disciplinary team”, in paragraph (b) for “persons for community care services” substitute “an adult’s needs for care and support”.
(4)
In Schedule 4 (services for rare and very rare conditions)—
(a)
“20A.
Alpha 1 antitrypsin services.”;
(b)
“36A.
Clinical genomic services.”;
(c)
“57ZA.
Gonadal tissue cryopreservation services for children and young people at high risk of gonadal failure due to treatment or disease.”;
(d)
“92A.
Psychological medicine inpatient services for severe and complex presentations of medically unexplained physical symptoms.”;
(e)
“104A.
Specialist adult haematology services.”;
(f)
omit paragraph 112;
(g)
“140AA.
Termination services for expectant mothers with significant comorbidities that require either or both critical care and medical support.”.
Amendment of the Care and Support (Provision of Health Services) Regulations 20143.
Amendment of the Care and Support (Assessment) Regulations 20144.
Signed by authority of the Secretary of State for Health and Social Care.
These Regulations amend the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 (S.I. 2012/2996), the Care and Support (Provision of Health Services) Regulations 2014 (S.I. 2014/2821) and the Care and Support (Assessment) Regulations 2014 (S.I. 2014/2827).
Regulation 2 amends the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 by up-dating certain definitions and the amounts of certain payments, up-dating references to the documents known as the National Framework for NHS Continuing Healthcare and NHS-funded Nursing Care, the Fast Track Pathway Tool for NHS Continuing Healthcare, the NHS Continuing Healthcare Checklist, and the Decision Support Tool for NHS Continuing Healthcare so that they refer to the most recent versions of those documents. It also amends Schedule 4 by adding to the list of services for rare and very rare conditions that may be provided as part of the health service to certain persons.
Regulation 3 amends the Care and Support (Provision of Health Services) Regulations 2014 to up-date the definition of the National Framework for NHS Continuing Healthcare and the NHS-funded Nursing care so that it refers to the most recent version of that Framework.
Regulation 4 amends the Care and Support (Assessment) Regulations 2014 to up-date the definition of the National Framework for NHS Continuing Healthcare and NHS-funded Nursing Care so that it refers to the most recent version of that Framework.
A full impact assessment has not been produced for this instrument as no, or no significant, impact on the private, voluntary or public sector is foreseen.